Chinese expert consensus on the diagnosis,treatment and management of hypertrophic cardiomyopathy in children(2025)
Precision Diagnosis and Treatment of Pediatric Cardiomyopathy Collaborative Group,Cardiovascular Group,Society of Pediatrics,Chinese Medical Association
Heart Failure Collaborative Group,Cardiovascular Group,Society of Pediatrics,Chinese Medical Association
Inherited Metabolic Cardiomyopathy Collaborative Group,Cardiovascular Group,Society of Pediatrics,Chinese Medical Association
Editorial Board of Chinese Journal of Applied Pediatrics
LI Zi-pu
TIAN Jie
YANG Shi-wei
Abstract：Hypertrophic cardiomyopathy(HCM)is one of the most important causes of sudden cardiac death in children and adolescents.Since the publication of the first Chinese consensus on pediatric HCM diagnosis in 2019,new and significant advances have been made in the diagnosis and management of HCM.To address these developments,the Cardiovascular Subspecialty Group of the Pediatrics Branch,Chinese Medical Association,in collaboration with the Precision Diagnosis and Treatment Collaborative Group for Childhood Cardiomyopathy,the Heart Failure Collaborative Group,the Genetic and Metabolic Cardiomyopathy Collaborative Group,and the Editorial Board of Chinese Journal of Practical Pediatrics,organized experts to develop this updated consensus.The consensus focuses on the definition,diagnostic approaches,risk stratification,and management of pediatric HCM,with the aim of improving the standardization of diagnosis and treatment of pediatric HCM,thereby enhancing its quality of life and improving prognosis.
Keywords：hypertrophic cardiomyopathydiagnosistreatmentmanagementchild
Publication Date：2025-08-06
Online Publishing Date：2025-09-30(First online date of this platform, not the publication date of the document)
Pages：20( 617-636 )